Neurosense Therapeutics is trading 11.4% up today at $0.52, benefiting from a broader risk-on mood and a strong session for biotech shares.
- The stock is moving sharply higher despite a lack of fresh company-specific news or filings, suggesting the rally is driven by volatility and sector sentiment.
- The biotechnology sector is seeing broad gains following solid earnings and active deal-making across the industry.